were removed prophylactically, either alone or together with other tumors, mainly vestibular or spinal schwannomas.
Sporadic Meningiomas
From 1981 to 1996, 992 patients without NF2 were surgically treated for a primary intracranial or spinal meningioma (hemangiopericytomas excluded) at the Department of Neurosurgery, Helsinki University Hospital. Thirty intracranial meningiomas removed during that time were selected for study; these tumors were obtained in 30 patients who were age-and gender-matched with the NF2 patients mentioned earlier (Table 2) . No signs of NF2 in the 30 patients appeared as of June 1996, the end of the study period (mean follow-up time 3.4 years, range 2 months-14 years) and none were found in reexamination of preoperative and follow-up CT or MR images. All of the sporadic meningiomas had caused symptoms before the operation. The maximum dimensions of the lesions were measured from the preoperative CT or MR images, which were available in 28 NF2 meningiomas and 28 sporadic meningiomas.
Histological Comparison of NF2 and Sporadic Meningiomas
Histological typing and grading (I-III) of the 65 meningioma samples, stained with hematoxylin and eosin, was performed by a
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Histological features and MIB-1 in sporadic and NF2-associated meningiomas 611 neuropathologist (M.H.) applying the criteria of the 1993 WHO classification of brain tumors. 13 In addition, the following morphological parameters were visually estimated and graded from 0 to 3: increased cellularity, nuclear pleomorphism, mitotic figures, and focal necroses.
Proliferation Index
The original specimens had been fixed in formaldehyde and embedded in paraffin. New representative sections (4-5 m) were dewaxed in xylene and rehydrated in graded series of ethanol to water. The Ki-67 nuclear antigen retrieval was performed in citrate buffer (pH 6) by means of the microwave oven processing technique. 4 The sections were treated two times for 7 minutes at 850 W in a microwave oven, after which the sections were allowed to cool in buffer for 30 minutes. For Ki-67 antigen immunostaining, the mouse monoclonal antibody MIB-1 (immunoglobulin G1; Immunotech S.A., Marseilles, France) was used at a concentration of 5 g/ml. The sections were incubated overnight at 4˚C, and the primary antibody was detected using the streptavidin-biotin technique (Zymed Laboratories Inc., San Francisco, CA). Counterstaining was performed using 0.4% ethyl green in acetate buffer for 15 minutes. Omission of the primary antibody provided a negative control, which was run on serial sections. Proliferative normal tissues (gut and skin) were used as positive controls on each run and analyzed.
The labeling indices (LIs) were calculated in a blinded fashion by one of the authors (J.A.) using a computer-assisted image analysis system (CAS-200 Software; Becton Dickinson, Mountain View, CA). The microscope-based system is equipped with two cameras that digitize the image of immunopositive (brown) and immunonegative (green) areas in cell nuclei for computer analysis. The staining results were scored as a percentage of the number of MIB-1-immunopositive tumor cell nuclei (MIB-1 LIs). Twenty microscopic fields (magnification ϫ 400) with the highest number of immunopositive nuclei were selected for analysis. Endothelial cells, necrotic and hemorrhagic areas, and section borders were excluded. The proliferation potential of 25 randomly selected meningioma slides was evaluated twice in a blinded fashion by the same observer (J.A.); the two consecutive MIB-1 counts showed a Pearson correlation coefficient of 0.947.
Statistical Analysis
Commercially available software (StatView IV; Abacus Concepts, Berkeley, CA) was used to compare the MIB-1 LIs of NF2 and sporadic meningiomas by means of the Mann-Whitney U-test, to correlate the MIB-1 LIs to the patient's age and the maximum diameter of the tumor by using the Pearson correlation coefficient and linear regression analysis, and to compare different morphological parameters and gender between NF2 and sporadic meningiomas by using the chi-square test.
Results
The mean age of the 23 NF2 patients (14 females and nine males) was 29 years (range 16-54 years); the mean age of the 30 age-and gender-matched non-NF2 patients (18 females and 12 males) was 31 years (range 15-53 years) ( Table 2 ). The age and gender differences were not statistically significant, which indicated successful matching. Meningothelial, fibroblastic, and transitional subtypes occurred equally among the NF2 meningiomas and the sporadic control meningiomas (Table 2) . When graded according to histological anaplasia, the 35 NF2 meningiomas consisted of 30 benign (WHO Grade I) and five atypical (WHO Grade II) tumors, and the 30 sporadic meningiomas consisted of 27 benign and three atypical tumors. The NF2 meningiomas displayed more mitotic figures (sum of grading points 24 vs. 7, p Ͻ 0.001) and nuclear pleomorphism (32 vs. 14, p = 0.003) than the sporadic ones.
The MIB-1 LIs (Table 3) were significantly higher in the 35 NF2 meningiomas than in the 30 sporadic meningiomas obtained in the age-and gender-matched non-NF2 cases (mean MIB-1 LIs: 2.5 vs. 1.75, p = 0.0147). The MIB-1 LIs did not correlate with the patients' ages at operation or with gender. The maximum diameter of 28 NF2 meningiomas increased with the MIB-1 LIs (r = 0.340, p = 0.077) and, accordingly, the 29 symptomatic NF2 meningiomas had higher LIs than the six incidentally discovered NF2 meningiomas (mean MIB-1 LIs, 2.84 vs. 1.40, p = 0.022). No correlation was found between the maximum diameter of the 28 sporadic meningiomas and their MIB-1 LIs (r = 0.005). As expected, the eight atypical meningiomas showed higher MIB-1 LIs than the 57 
Discussion
The histological features and proliferation potential in what is so far the largest series of meningiomas obtained in NF2 patients were compared with those found in sporadic meningiomas obtained in age-and gender-matched patients without NF2. As in schwannomas, 1, 2 we found a significant difference in the proliferation potential between NF2 and sporadic meningiomas. In line with this finding, we observed a more frequent incidence of mitotic figures and nuclear pleomorphism in NF2 meningiomas than in sporadic ones.
The MIB-1 Labeling Indices in Meningiomas
In many studies MIB-1 labeling has been used to assess the proliferative potential of meningiomas, 12, 14, 19, 20 but none of these studies included patients with NF2. Tables 2  and 3 offer summaries of three large MIB-1 studies on what were believed to be sporadic meningiomas, based on the examination of paraffin-embedded tissue samples and application of the 1993 WHO classification criteria for brain tumors. In our study, the MIB-1 LIs of the NF2 meningiomas were higher than the mean LIs from these studies (Table 3) . Interestingly, the MIB-1 LIs of the sporadic meningiomas in age-matched patients were also slightly higher than the means from these three studies, in part indicating the more aggressive nature of meningiomas in younger patients. 6 
Histological Findings in NF2 Meningiomas
To our knowledge, no previous morphological comparison between sporadic and NF2 meningiomas has been reported. We did not observe any specific histological feature that would distinguish NF2 meningiomas from the sporadic control tumors; however, signs of anaplasia occurred more frequently in NF2 meningiomas, in line with the MIB-1 findings. In our study of 35 NF2 meningiomas, the fibroblastic variant was clearly overrepresented (26%) and the meningothelial one was unusual (14%), a reversal of their ratio in sporadic meningiomas. 14, 18 Variants of meningioma seem to differ significantly in their frequency of detected NF2 mutations; NF2 gene mutations were found in 25% of meningothelial meningiomas as compared with 70% of fibroblastic and 83% of transitional meningiomas, 33 indicating a different molecular pathogenesis in these meningioma variants. Surprisingly, fibroblastic meningiomas comprised 30% of our young age-matched control group, although a pure fibroblastic subtype seems to be rare in unselected sporadic meningiomas; 11, 25 this difference in meningioma subtypes may reflect age-related differences rather than NF2 generelated differences. In schwannomas, there are certain morphological differences between NF2 and sporadic tumors: 40% of vestibular NF2 schwannomas show a lobular, grapelike pattern, which is extremely uncommon in sporadic schwannomas; 31 in addition, vestibular schwannomas in NF2 infiltrate the adjacent facial nerve more often. 10 
Patients With NF2
Neurofibromatosis 2 occurs equally often in men and women 8, 23 and no predilection for vestibular schwannomas in either gender has been observed. 7 On the other hand, NF2 meningiomas appear more often in women, 7 similar to sporadic meningiomas, a characteristic that was also seen in our study. The female predominance suggests a similar pathogenesis for both tumors. Although age does not seem to be a factor in the MIB-1 LIs of schwannomas 1,2 or meningiomas, 20 in an attempt to control for this variable, we selected an age-and gender-matched control group of 30 patients with sporadic meningiomas. However, we cannot definitely rule out late onset NF2 in the control patients because the mean follow-up time after surgery was only 3.4 years. In addition, as many as 14 of the 35 NF2 meningiomas, compared with five of the 30 sporadic control meningiomas, were located in the posterior fossa. This is because most of the NF2 patients (Cases 6-23, Table 1 ) were surgically treated in a neurosurgical unit (Nordstadt Hospital) that specializes in skull base surgery. However, the site of the meningioma does not seem to be a factor in MIB-1 LIs of meningiomas. 20 
Difference in Proliferation Potential
There are at least three possible explanations for the observed difference in proliferation potential between NF2-associated and sporadic meningiomas. First, other genes could be altered in sporadic meningiomas. Loss of heterozygosity for chromosome 22q is found in up to 70% of sporadic meningiomas; 28 however, NF2 gene defects are only detected in approximately 33% of meningiomas, 5, 15, 22, 33 indicating that another tumor suppressor gene or genes in chromosome 22q may play a role in the pathogenesis of sporadic meningiomas. One such candidate gene is BAM22 on chromosome 22, a member of the ␤-adaptin gene family, which may be inactivated in some sporadic meningiomas. 24 In atypical and malignant meningiomas, genes other than the NF2 gene seem to be associated with malignant progression, as indicated by frequent deletions on chromosomes 1p, 10q, and 14q. 30 Second, the difference in proliferation rate could reflect the variation in the mutational spectrum of the NF2 gene in sporadic and NF2 meningiomas. Two recent studies have suggested an association between patients with NF2 who exhibit a mild clinical course and harbor slow-growing tumors and NF2 gene mutations that preserve the COOH terminus of the protein, whereas grossly truncating mutations result in the more severe phenotype with rapid-growing tumors. 18, 27 On the other hand, two unrelated patients with NF2 and the same constitutional NF2 mutation may have either a mild or severe phenotype because of somatic mosaicism. 3 Additional multicenter studies are needed to clarify the degree of genotype-phenotype correlation in NF2. Third, the tissue surrounding meningiomas may be different in patients with NF2 who only have one functional NF2 gene. This could lead to a decreased production of NF2 protein and changes in the ability of the host to resist the growth and invasion of meningiomas.
Conclusions
The higher proliferation potential of NF2 meningiomas may reflect differences in molecular biology between spo-radic and NF2 meningiomas and may be related to an earlier onset, multiplicity, and more aggressive behavior of NF2-associated tumors.
